Latest on pharmacogenomic testing

Article

A look at the current understanding of pharmacogenomic testing and how it can help with treating behavioral health issues.

Pharmacogenomics can have many applications and a presentation at the 2020 Virtual Conference on Pediatric Health Care by Kimberly Erlich, MSN, RN, MPH, CPNP, PMHS, offered a look at the current understanding of pharmcogenomic testing and how it can help with treating behavioral health issues.

She discussed how pharmacogenomics testing can help consider the most up-to-date treatments available because medications may have a different response because of genetic variations. Additionally, more than 40 neuropsychiatric medications currently list gene-drug interactions, which can be difficult to effectively use without the aid of something like pharmacogenic testing.

For clinicians who are considering pharmacogenic testing, Erlich said that there are 2 schools of thought. One considers testing to be appropriate before prescribing any medication in order to use it as a guide. The other school of thought considers testing appropriate to aid in monitoring patient response.

For more on the presentation, check out our sister publication Contemporary Clinic.

Related Videos
Tina Tan, MD, FAAP, FIDSA, FPIDS
Related Content
© 2024 MJH Life Sciences

All rights reserved.